Leveraging Lessons From 3 Decades of Procalcitonin Testing: Procalcitonin Dos and Don'ts

This webinar was recorded live on September 5, 2024.
It is available on demand through September 30, 2025.
Register above for access

Description

Join our webinar to discover the foundations of Procalcitonin (PCT) testing and its successful implementation in antibiotic stewardship programs. Learn about its applications in management of sepsis and lower respiratory tract infections, optimizing antibiotic use and positively impacting budgets. Available assays, clinical validation, and standardization implications will also be reviewed.

Target audience

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, residents, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.

Learning objectives

At the end of this session, participants will be able to:

• Summarize the role of Procalcitonin in the management of sepsis and lower respiratory tract infections.
• Recognize the impact of Procalcitonin on antibiotic stewardship, including its influence on antibiotic use, mortality rates, and the C. difficile infection incidence and antibiotic resistance.
• Compare and contrast available Procalcitonin assays, understanding their differences and applications.
• Describe strategies to maximize the clinical and economic benefits of Procalcitonin testing within antibiotic stewardship programs.

Faculty

Joshua Hayden, PhD, DABCC, FADLM
Chief of Chemistry
Norton Healthcare
Louisville, KY, USA

Susan Dawson, MBA, MT(ASCP)
Laboratory Administrative and Operations Director
Endeavor Health
Chicago, IL, USA

Thomas File, MD, MSc, MACP, FIDSA, FCCP
Distinguished Physician, Division of Infectious Disease
Summa Health
Akron, OH, USA

Moderator

Alison Woodworth, PhD, DABCC, FADLM
Clinical Director, Global Laboratory Services
CTI Clinical Trials & Consulting
Cincinnati, OH, USA

Disclosures and statement of independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported financial relationships:

• Joshua Hayden, PhD, DABCC, FADLM
  • Honorarium/Expenses: Thermo Fisher
  • Grant/Research Support: Gilead
  • Board/Committee Membership/Advisory Board: BioPorto
• Susan Dawson, MBA, MT(ASCP)
  • Honorarium/Expenses: Siemens Healthineers
• Thomas File, MD, MSc, MACP, FIDSA, FCCP
  • Honorarium/Expenses: Thermo Fisher, Paratek
  • Consultant Fee: ThermoFisher, Paratek
  • Board/Committee Membership/Advisory Board: MicroGenDx, HealthTrackRX, Shionogi, Merck, Eagle Pharmaceuticals
• Alison Woodworth, PhD, DABCC, FADLM
  • Salary: CTI Clinical Trails & Consulting

Content validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation statement

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID #4323. This activity was planned in accordance with ACCENT® Standards and Policies.

Successful completion statement

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].